The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...

Synthetic Oligonucleotides are set for rapid expansion in healthcare, food production, and data storage. The technology, vital in both existing and new markets, promises vast growth potential often ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, function, and interactions. Proteomics plays a critical role in understanding ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

By Vijay Kumar Malesu Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...

SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...